Long Term Prognostic Utility of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome - A Systematic Review.

CONCLUSION: MMP-9 can be a potential prognostic marker for ACS and aid in identifying high risk patients for intensive management during follow -up.
PMID: 32619165 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Biotechnology - July 2, 2020 Category: Biotechnology Authors: Das A, George M, Jha D, Goenka L Tags: Curr Pharm Biotechnol Source Type: research